9 studies found for:    Open Studies | "Norovirus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Norovirus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)
Condition: Gastroenteritis Norovirus
Interventions: Biological: Norovirus GII.4 Challenge Pool CIN-1;   Other: Placebo
2 Not yet recruiting Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis Norovirus
Interventions: Biological: Snow Mountain stool filtrate;   Other: Placebo
3 Recruiting Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Children
Condition: Norovirus
Interventions: Biological: GI.1/GII.4 (15/15) - MPL (50);   Biological: GI.1/GII.4 (15/50) - MPL (50);   Biological: GI.1/GII.4 (50/50) - MPL (50);   Biological: GI.1/GII.4 (15/15) - MPL (15);   Biological: GI.1/GII.4 (15/50) - MPL (15);   Biological: GI.1/GII.4 (50/50) - MPL (15);   Biological: GI.1/GII.4 (15/15);   Biological: GI.1/GII.4 (15/50);   Biological: GI.1/GII.4 (50/50);   Biological: GI.1/GII.4 (50/150);   Biological: GI.1/GII.4 (15/50) - Al(OH)3 (167);   Drug: Placebo
4 Recruiting Human Breastmilk in Young Children With Norovirus Infection of the Gut
Condition: Norovirus Infections
Intervention: Biological: Donor Breastmilk
5 Recruiting Secondary Lactose Intolerance Due to Chronic Norovirus Infection
Condition: Chronic Diarrhea
Intervention: Behavioral: Lactose H2 breath test (LH2BT)
6 Recruiting A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Condition: Acute Gastroenteritis
7 Recruiting NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
Condition: Advanced Refractory Solid Tumors
Intervention: Drug: NOV120401
8 Recruiting Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
Condition: Metastatic Breast Cancer
Intervention: Drug: NOV120101 (Poziotinib)
9 Recruiting Viral Infections in Healthy and Immunocompromised Hosts
Condition: Herpes Viruses

Indicates status has not been verified in more than two years